Literature DB >> 12576178

Nociceptin immunoreactivity and receptor mRNA in the human trigeminal ganglion.

Mingyan Hou1, Rolf Uddman, Janos Tajti, Lars Edvinsson.   

Abstract

Nociceptin is a peptide transmitter belonging to the opioid family. Nociceptin has recently attracted considerable interest since it appears to exhibit a number of differences to the other opioids. In the present study, we used a nociceptin antibody to map the distribution of nociceptin in the human trigeminal ganglion. In addition, we studied the nociceptin receptor at mRNA levels by RT-PCR and the vasomotor response to nociceptin in human cerebral vessels using a sensitive in vitro method. About 70% of all neuronal cells in trigeminal ganglia were nociceptin immunopositive. Nociceptin was predominantly (78%) expressed in medium-sized cells (30-60 microm). Nociceptin also distributed in small-sized cells (14% of positive cell bodies; <30 microm) and in large-sized cells (8% of positive cell bodies; >60 microm). Double immunostaining showed that in the human trigeminal ganglion nociceptin colocalized with calcitonin gene-related peptide (CGRP), substance P (SP), nitric oxide synthase (NOS) or pituitary adenylate cyclase activating peptide (PACAP). About 61% of nociceptin positive cells contained CGRP, 54% contained SP, 50% contained NOS and 68% contained PACAP. Immunoreactivity to nociceptin was not detected in human cerebral blood vessels. Reverse transcriptase-polymerase chain reaction detected the expression of nociceptin receptor mRNA in trigeminal ganglia but not in basilar arteries. To further examine whether there are functional nociceptin receptors in human cerebral arteries, a pharmacological study was done, where cerebral arteries revealed strong contractions to 60 mM K(+) and U466166 and strong relaxation to CGRP. Nociceptin failed to elicit contraction or relaxation. In conclusion, nociceptin is expressed in human trigeminal ganglia but not in cerebral blood vessels. Nociceptin is colocalized with CGRP, SP, NOS and PACAP. Nociceptin receptor mRNA is expressed in human trigeminal ganglia but not in basilar arteries. The functional role of nociceptin may be at the presynaptic level.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576178     DOI: 10.1016/s0006-8993(02)03927-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Intraneuronal angiotensinergic system in rat and human dorsal root ganglia.

Authors:  Jaspal Patil; Alexander Schwab; Juerg Nussberger; Thomas Schaffner; Juan M Saavedra; Hans Imboden
Journal:  Regul Pept       Date:  2010-03-24

2.  NOP receptor agonist attenuates nitroglycerin-induced migraine-like symptoms in mice.

Authors:  Katarzyna M Targowska-Duda; Akihiko Ozawa; Zachariah Bertels; Andrea Cippitelli; Jason L Marcus; Hanna K Mielke-Maday; Gilles Zribi; Amanda N Rainey; Brigitte L Kieffer; Amynah A Pradhan; Lawrence Toll
Journal:  Neuropharmacology       Date:  2020-03-06       Impact factor: 5.250

3.  Current understanding of trigeminal ganglion structure and function in headache.

Authors:  Karl Messlinger; Andrew F Russo
Journal:  Cephalalgia       Date:  2018-07-10       Impact factor: 6.292

4.  Endogenous angiotensinergic system in neurons of rat and human trigeminal ganglia.

Authors:  Hans Imboden; Jaspal Patil; Juerg Nussberger; Françoise Nicoud; Benno Hess; Nermin Ahmed; Thomas Schaffner; Maren Wellner; Dominik Müller; Tadashi Inagami; Takaaki Senbonmatsu; Jaroslav Pavel; Juan M Saavedra
Journal:  Regul Pept       Date:  2009-02-12

5.  N/OFQ modulates orofacial pain induced by tooth movement through CGRP-dependent pathways.

Authors:  Xinyu Yan; Han Han; Shizhen Zhang; Yanzhu Lu; Linghuan Ren; Yufei Tang; Xiaolong Li; Fan Jian; Yan Wang; Hu Long; Wenli Lai
Journal:  BMC Neurosci       Date:  2021-04-09       Impact factor: 3.288

6.  Cellular localization of aquaporin-1 in the human and mouse trigeminal systems.

Authors:  Junying Gao; Meiyun Tan; Minxia Gu; Charles Marshall; Jiong Ding; Gang Hu; Ming Xiao
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

Review 7.  The NOP Receptor System in Neurological and Psychiatric Disorders: Discrepancies, Peculiarities and Clinical Progress in Developing Targeted Therapies.

Authors:  Lawrence Toll; Andrea Cippitelli; Akihiko Ozawa
Journal:  CNS Drugs       Date:  2021-05-31       Impact factor: 6.497

Review 8.  PACAP and its role in primary headaches.

Authors:  Lars Edvinsson; János Tajti; Levente Szalárdy; László Vécsei
Journal:  J Headache Pain       Date:  2018-03-09       Impact factor: 7.277

Review 9.  Neuropeptides and ATP signaling in the trigeminal ganglion.

Authors:  Tetsuya Goto; Haruki Iwai; Eriko Kuramoto; Atsushi Yamanaka
Journal:  Jpn Dent Sci Rev       Date:  2017-03-15

Review 10.  Cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators.

Authors:  Karl Messlinger; Louis K Balcziak; Andrew F Russo
Journal:  J Neural Transm (Vienna)       Date:  2020-02-22       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.